BCR-ABL Real-Time PCR Kit

Qualitative Detection of the BCR-ABL Fusion Gene for CML & Ph-Positive Leukemia Diagnosis

Early and accurate diagnosis is essential in leukemia management. The BCR-ABL Real-Time PCR Kit enables fast, qualitative detection of BCR-ABL fusion transcripts (Major, Minor & Micro breakpoints) directly from blood and bone marrow RNA. Tailored for molecular oncology testing, the kit empowers hematology centers and cancer specialists to confirm Philadelphia-chromosome–associated leukemia efficiently and guide treatment decisions with confidence.

tuberculosis

Overview

The BCR-ABL Real-Time PCR Kit is a multiplex RT-PCR–based in-vitro diagnostic test designed for rapid, qualitative detection of BCR-ABL (Mbcr) fusion gene transcripts. The assay supports leukemia diagnosis workflows, helping clinicians classify CML and Ph-positive ALL patients quickly, even in settings without access to full cytogenetic analysis. Compatible with OnePCR® Ultra-Fast POC System and Rapi-Q® POC PCR System, the kit fits both centralized labs and point-of-care oncology units.

Targets Detected: The panel includes
BCR-ABL1 Major breakpoint
BCR-ABL1 Minor breakpoint
BCR-ABL1 Micro breakpoint
Internal Control – ABL1 gene (monitors RNA integrity & assay validity)

BCR ABL Applications

HHv-Q
  • Diagnostic confirmation of Philadelphia-positive CML
  • Detection of BCR-ABL–associated ALL (Ph+ B-ALL)
  • Rapid leukemia workup in oncology, pediatric & hematology units
  • Point-of-care diagnostic support in resource-limited cancer centers
  • Pre-treatment molecular classification for targeted therapy decisions

Key Features

Multiplex detection of 3 major breakpoint transcripts in a single workflow
Works with total RNA extracted from whole blood or bone marrow
Lyophilized reagents for easy setup and long-term storage
Compatible with OnePCR® fully automated extraction-to-PCR workflow
Compatible with Rapi-Q® rapid PCR platform for manual tube-based testing
Internal control ensures reliable true-negative results

Workflow / How It Works

With OnePCR® Portable Ultra-Fast POC System
OnePCR® workflow

Collect blood or bone marrow sample | Extract RNA & load into lyophilized PCR cartridge | Insert cartridge into OnePCR devic | Automated sample processing & multiplex RT-PCR | Results displayed as Positive / Negative + Ct values

With Rapi-Q® System
Rapi-Q workflow

Perform RNA extraction using Rapi-X16 module | Reconstitute lyophilized ready-mix tubes | Add RNA sample & load into Rapi-Q block | Run BCR-ABL program view results in real time

Ordering Information

Commercial Name Cat No. Pack Size Compatible Instruments
BCR-ABL Real-Time PCR Kit G2M708921R - 24T 24 Tests OnePCR Ultra-Fast POC System
BCR-ABL Real-Time PCR Kit G2M708921R - 48T 48T Rapi-Q Portable PCR Device

Why Choose the BCR-ABL Kit?

Enables rapid molecular leukemia confirmation
Reduces dependency on time-consuming cytogenetics
Supports hematology-oncology decisions at point-of-care
Designed for both centralized labs & bedside oncology units

Resources to get started

Download useful documents and technical information for the BCR ABL RT-PCR Kit.

Product Brochure
IFU (Instructions for Use)
Report File

Product Enquiry Form

Other Products

Rapi-Q Series
Rapi-Q

Rapid and Compact Point-of-care RT-PCR Testing Solution.

Rapi-X96
Rapi-X96

High Throughput fully Automated Nucleic Acid Extraction System.

TRapi-X96
Rapi-X16

Compact Nucleic Acid Extraction System Ideal for Point-of-Care Testing

Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.

All products listed in the catalogue are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used in the catalogue are the property of their respective owners.

© 2025 Genes2me. All rights reserved.